메뉴 건너뛰기




Volumn 3, Issue 1, 2007, Pages 19-27

QSAR analysis of HIV-1 reverse transcriptase inhibitory 5-alkyl-2-[(aryl and alkyloxycarbonlmethyl) thio]-6- (1-napthylmethyl) pyrimidin-4 (3H)-ones

Author keywords

HIV 1 reverse transcriptase inhibitors; MOE; NNRTIs; QSAR; S DABO

Indexed keywords

5 ALKYL 2 [(ALKYLOXYCARBONYLMETHYL)THIO] 6 (1 NAPHTHYLMETHYL)PYRIMIDINE 4 (3H) ONE DERIVATIVE; 5 ALKYL 2 [(ARYLCARBONYLMETHYL)THIO] 6 (1 NAPHTHYLMETHYL)PYRIMIDINE 4 (3H) ONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

EID: 37649005719     PISSN: 18164900     EISSN: None     Source Type: Journal    
DOI: 10.3923/ijv.2007.19.27     Document Type: Article
Times cited : (3)

References (32)
  • 1
    • 0033081564 scopus 로고    scopus 로고
    • Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase
    • Bacheler, L.T., 1999. Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase. Drug Resist. Updates, 2: 56-67.
    • (1999) Drug Resist. Updates , vol.2 , pp. 56-67
    • Bacheler, L.T.1
  • 2
    • 8844285333 scopus 로고    scopus 로고
    • Balaji, S., C. Karthikeyan, N.S. Hari Narayan Moorthy and P. Trivedi, 2004. QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors. Bioorg. Med. Chem. Lett., 14: 6089-6094.
    • Balaji, S., C. Karthikeyan, N.S. Hari Narayan Moorthy and P. Trivedi, 2004. QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors. Bioorg. Med. Chem. Lett., 14: 6089-6094.
  • 3
    • 0026694001 scopus 로고
    • 2′,5′-Bis-O-(tert-butyldimethylsilyl)]- 3′-spiro- 5″- (4″-amino-1″,2″-oxathiole-2″,2″-,dioxide) (TSAO) derivatives of purine and pyrimidine nucleosides; as potent and selective inhibitors of human immunodeficiency virus type 1
    • Balzarini, J., M.J. Pe'rez-Pe'rez, A- San-Fe'lix, S. Vela'zquez, MJ. Camarasa and E. De Clercq, 1992. [2′,5′-Bis-O-(tert-butyldimethylsilyl)]- 3′-spiro- 5″- (4″-amino-1″,2″-oxathiole-2″,2″-,dioxide) (TSAO) derivatives of purine and pyrimidine nucleosides; as potent and selective inhibitors of human immunodeficiency virus type 1. Antimicrob. Agents Chemother., 36: 1073-1080.
    • (1992) Antimicrob. Agents Chemother , vol.36 , pp. 1073-1080
    • Balzarini, J.1    Pe'rez-Pe'rez, M.J.2    San-Fe'lix, A.3    Vela'zquez, S.4    Camarasa, M.J.5    De Clercq, E.6
  • 4
    • 0343831900 scopus 로고    scopus 로고
    • Quantitative Structure-Activity Relationship (QSAR) study of new fluorovinyloxyacetamides
    • Cho, D.H., S.K. Lee, B.T. Kim and K.T. No, 2001. Quantitative Structure-Activity Relationship (QSAR) study of new fluorovinyloxyacetamides. Bull. Korean Chem. Soc., 22: 388-394.
    • (2001) Bull. Korean Chem. Soc , vol.22 , pp. 388-394
    • Cho, D.H.1    Lee, S.K.2    Kim, B.T.3
  • 5
    • 0028248489 scopus 로고
    • Augest, J, M.W. Ander, F. Murad Eds, San Diego, Academic, pp
    • Darke, P.L. and JR. Huff, 1994. Advances in Pharamacology. Augest, J., M.W. Ander, F. Murad (Eds.), San Diego, Academic, pp: 399-415.
    • (1994) Advances in Pharamacology , pp. 399-415
    • Darke, P.L.1    Huff, J.R.2
  • 6
    • 0029011730 scopus 로고
    • Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections
    • De Clercq E., 1995. Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J. Med, Chem., 38: 2491-2517.
    • (1995) J. Med, Chem , vol.38 , pp. 2491-2517
    • De Clercq, E.1
  • 7
    • 0032437454 scopus 로고    scopus 로고
    • The role of non-nucleoside reverses transcriptase inhibitors (NNRTTs) in the therapy of HIV- 1 infection
    • Do Clercq, E., 1998. The role of non-nucleoside reverses transcriptase inhibitors (NNRTTs) in the therapy of HIV- 1 infection. Antiviral Res., 38: 153-179.
    • (1998) Antiviral Res , vol.38 , pp. 153-179
    • Do Clercq, E.1
  • 8
    • 0033927489 scopus 로고    scopus 로고
    • Novel compounds in preclinical/early clinical development for the treatment of HIV infections
    • Do Clercq, E., 2000. Novel compounds in preclinical/early clinical development for the treatment of HIV infections. Rev. Med. Virol., 10: 255-277.
    • (2000) Rev. Med. Virol , vol.10 , pp. 255-277
    • Do Clercq, E.1
  • 9
    • 0035271620 scopus 로고    scopus 로고
    • Do Clercq, E., 2 001. New developments in anti-HIV chemotherapy. II Farmaco, 56: 3-12.
    • Do Clercq, E., 2 001. New developments in anti-HIV chemotherapy. II Farmaco, 56: 3-12.
  • 10
    • 0036846898 scopus 로고    scopus 로고
    • Now anti-HIV agents and targets
    • Do Clercq, E., 2002a. Now anti-HIV agents and targets. Med- Res. Rev., 22: 531-565.
    • (2002) Med- Res. Rev , vol.22 , pp. 531-565
    • Do Clercq, E.1
  • 11
    • 0037130296 scopus 로고    scopus 로고
    • New developments in anti-HIV chemotherapy
    • DeClercq, E., 2002b. New developments in anti-HIV chemotherapy. Biochim. Biophys. Acta, 1587: 258-275.
    • (2002) Biochim. Biophys. Acta , vol.1587 , pp. 258-275
    • DeClercq, E.1
  • 12
    • 0031805095 scopus 로고    scopus 로고
    • S-1153 inMbits replication of known drug-resistant strains of human immunodeficiency virus type 1
    • Fujiwara, T., A. Sato, M. El-Farrash S. Miki and K. Abe et al., 1998. S-1153 inMbits replication of known drug-resistant strains of human immunodeficiency virus type 1. Antimicrob. Agents Chemother., 42: 1340-1345.
    • (1998) Antimicrob. Agents Chemother , vol.42 , pp. 1340-1345
    • Fujiwara, T.1    Sato, A.2    El-Farrash, M.3    Miki, S.4    Abe, K.5
  • 13
    • 1542301644 scopus 로고    scopus 로고
    • QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters
    • Gayen, S., B. Debnath, S. Samantha and T. Jha, 2004. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters, Biorg. Med. Chem., 12: 1493-1503.
    • (2004) Biorg. Med. Chem , vol.12 , pp. 1493-1503
    • Gayen, S.1    Debnath, B.2    Samantha, S.3    Jha, T.4
  • 14
    • 0026003110 scopus 로고    scopus 로고
    • Goldman, M.E., J.H. Nunberg, J.A. O'Brien, J.C. Quintero andW.A. Schleif et al., 1991. Pyridone derivatives: Specific human immunodeficiency virus type I reverse transcriptase inhibitors with antiviral activity. Proc. Natl. Acad. Sci. USA., 88: 6863-6867.
    • Goldman, M.E., J.H. Nunberg, J.A. O'Brien, J.C. Quintero andW.A. Schleif et al., 1991. Pyridone derivatives: Specific human immunodeficiency virus type I reverse transcriptase inhibitors with antiviral activity. Proc. Natl. Acad. Sci. USA., 88: 6863-6867.
  • 15
    • 0000805679 scopus 로고
    • The molecular comectivity chi indices and kappa shape indices in structure-property modeling. Rev. Comput. Chem
    • Hall, L.H. and L.B. Kier, 1991. The molecular comectivity chi indices and kappa shape indices in structure-property modeling. Rev. Comput. Chem., Vol. 2.
    • (1991) , vol.2
    • Hall, L.H.1    Kier, L.B.2
  • 16
    • 2442610540 scopus 로고    scopus 로고
    • 5-Alkyl-2-[(aryl and alkyloxyicarbonylmeth)thio]-6- (1-naphthy1methyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series
    • He, Y., C. Fener, S. Guangfu, W. Yueping, E. De Clercq, J. Balzarini and C. Pannecouque, 2004. 5-Alkyl-2-[(aryl and alkyloxyicarbonylmeth)thio]-6- (1-naphthy1methyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S-DABO series. Bioorg. Med. Chem. Left., 14: 3173-3176.
    • (2004) Bioorg. Med. Chem. Left , vol.14 , pp. 3173-3176
    • He, Y.1    Fener, C.2    Guangfu, S.3    Yueping, W.4    De Clercq, E.5    Balzarini, J.6    Pannecouque, C.7
  • 17
    • 0034059835 scopus 로고    scopus 로고
    • no HIV-1 reverse transcription (RT) process as target for RT inhibitors
    • Jonckheere, H., J. Anne and F. Do Clercq, 2000. no HIV-1 reverse transcription (RT) process as target for RT inhibitors. Med. Res. Rev., 20: 129-154.
    • (2000) Med. Res. Rev , vol.20 , pp. 129-154
    • Jonckheere, H.1    Anne, J.2    Clercq, F.D.3
  • 18
    • 0017754506 scopus 로고
    • Structure-activity studies on hallucinogenic amphetamines using molecular connectivity
    • Kier, L.B. and L.H. Hall, 1977. Structure-activity studies on hallucinogenic amphetamines using molecular connectivity. J. Med. Chem., 20: 1631-1636.
    • (1977) J. Med. Chem , vol.20 , pp. 1631-1636
    • Kier, L.B.1    Hall, L.H.2
  • 19
    • 2942550228 scopus 로고    scopus 로고
    • Classical QSAR Modeling of HIv'-1 Reverse Transcriptase InNbitor 2-Amino-6-arysulfonylbenzonitriles and Congeners
    • Leonard. J. and K. Rov, 2001. Classical QSAR Modeling of HIv'-1 Reverse Transcriptase InNbitor 2-Amino-6-arysulfonylbenzonitriles and Congeners. QSAR Combi. Sci., 23: 23-35.
    • (2001) QSAR Combi. Sci , vol.23 , pp. 23-35
    • Leonard, J.1    Rov, K.2
  • 20
    • 37649011078 scopus 로고    scopus 로고
    • Lin, A., 1997. QuaSAR-descriptors, Journal of Chemical Computing Group. http:/!www.chemcomp.com/Journal_of_CCG/Faatures/descr.htm.
    • Lin, A., 1997. QuaSAR-descriptors, Journal of Chemical Computing Group. http:/!www.chemcomp.com/Journal_of_CCG/Faatures/descr.htm.
  • 21
    • 17944376896 scopus 로고    scopus 로고
    • Evolution of anti-HIV drug candidates. Part 1: From R-Anilinophenylixetamide (RAPA) to imidazolyl thiourea (ITU)
    • Ludovici, D.W., MT Kukla, P.G. Grous, S. Krishnan and K. Andries et al., 2001. Evolution of anti-HIV drug candidates. Part 1: From R-Anilinophenylixetamide (RAPA) to imidazolyl thiourea (ITU). Bioorg. Med. Chem. Lett., 11: 2225-2228.
    • (2001) Bioorg. Med. Chem. Lett , vol.11 , pp. 2225-2228
    • Ludovici, D.W.1    Kukla, M.T.2    Grous, P.G.3    Krishnan, S.4    Andries, K.5
  • 22
    • 0001728908 scopus 로고    scopus 로고
    • Quantum-chernical descriptors in QSAR/ QSPR studies
    • Mati, K. and V.S. Lobanov, 1996 Quantum-chernical descriptors in QSAR/ QSPR studies. Chem. Rev., 96: 1027-1043.
    • (1996) Chem. Rev , vol.96 , pp. 1027-1043
    • Mati, K.1    Lobanov, V.S.2
  • 23
    • 2642709177 scopus 로고    scopus 로고
    • MOE., 2002. Molecular modeling package developed by chemical Computing Group Inc., Canada. Palella, F.J., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman and S.D. Holmberg, 1998. For the HIV outpatient study investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infecfion. N. Eng. J. Med., 338: 853-860.
    • MOE., 2002. Molecular modeling package developed by chemical Computing Group Inc., Canada. Palella, F.J., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman and S.D. Holmberg, 1998. For the HIV outpatient study investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infecfion. N. Eng. J. Med., 338: 853-860.
  • 24
    • 0025014499 scopus 로고
    • Potent and selective irffiffition of HIV- I replication in vitro by a novel series of TIBO derivatives
    • Pauwels, R., K. Andries, J. Desmijter, D. Schols and M.J. Kukla et al., 1990. Potent and selective irffiffition of HIV- I replication in vitro by a novel series of TIBO derivatives. Nature, 343: 470-474.
    • (1990) Nature , vol.343 , pp. 470-474
    • Pauwels, R.1    Andries, K.2    Desmijter, J.3    Schols, D.4    Kukla, M.J.5
  • 25
    • 0027407551 scopus 로고
    • Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of R-anilinophenylacetamide derivatives targeted at HIV-I reverse transcriptase
    • Pauwels, R., K. Andries, Z. Debryser, P. Van Dacle and D. Schols et al., 1993, Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of R-anilinophenylacetamide derivatives targeted at HIV-I reverse transcriptase. Proc. Natl. Acad. Sci. USA., 90: 1711-1715.
    • (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 1711-1715
    • Pauwels, R.1    Andries, K.2    Debryser, Z.3    Van Dacle, P.4    Schols, D.5
  • 26
    • 0000697995 scopus 로고    scopus 로고
    • Petitjean, M., 1992. Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds. J. Chem. In[ Comput. Sci., 32: 331-337.
    • Petitjean, M., 1992. Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds. J. Chem. In[ Comput. Sci., 32: 331-337.
  • 28
    • 8544239371 scopus 로고    scopus 로고
    • CP-MLR/PLS Directed structure-activity modeling of die HIV- 1 RT inhibitory activity of 2,3-Diaryl- 1,3-thiazolidin-4- ones
    • Prabhakar, Y.S., V.F. Soloman, R.K. Rawal, M.K. Gupta and S.B. Katti, 2004. CP-MLR/PLS Directed structure-activity modeling of die HIV- 1 RT inhibitory activity of 2,3-Diaryl- 1,3-thiazolidin-4- ones. QSAR Combi. Sci., 23: 234-244.
    • (2004) QSAR Combi. Sci , vol.23 , pp. 234-244
    • Prabhakar, Y.S.1    Soloman, V.F.2    Rawal, R.K.3    Gupta, M.K.4    Katti, S.B.5
  • 30
    • 0027094782 scopus 로고    scopus 로고
    • SYSTAT 10.2, 2003. A statistical package developed by SYSTAT software Inc, USA, 2003. Tanaka, H., H. Takashima, M. Ubasawa, K. Sekiya, I. Nitta, M. Baba, S. Shigeta, R.T. Walker, E. De Clercq and T. Miyasaka, 1992. Synthesis and antiviral activity of 1-[(2-bydroxycthoxy)-methl]-6-(phenylthio)thyminc (HEPT) as potent and selective anti-HIV-1 agents. J. Med. Chem., 35: 4713-4719.
    • SYSTAT 10.2, 2003. A statistical package developed by SYSTAT software Inc, USA, 2003. Tanaka, H., H. Takashima, M. Ubasawa, K. Sekiya, I. Nitta, M. Baba, S. Shigeta, R.T. Walker, E. De Clercq and T. Miyasaka, 1992. Synthesis and antiviral activity of 1-[(2-bydroxycthoxy)-methl]-6-(phenylthio)thyminc (HEPT) as potent and selective anti-HIV-1 agents. J. Med. Chem., 35: 4713-4719.
  • 31
  • 32
    • 8544254107 scopus 로고
    • Structural determination of paraffin boiling points
    • Wiener, H., 1947. Structural determination of paraffin boiling points. J. Am. Chem. Soc., 69: 17-20.
    • (1947) J. Am. Chem. Soc , vol.69 , pp. 17-20
    • Wiener, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.